Autres langues Cosmos Health Inc.

Actions

COSM

US2214133058

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 16/07/2024			Varia. 5j.	Varia. 1 janv.
1,46 ^USD	+3,55 %		+22,69 %	+3,55 %

02/07	Cosmos Health étend sa collaboration avec Papaellinas à Chypre	CI
01/07	Mise à jour sectorielle : Les actions du secteur de la santé reculent en fin d'après-midi	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cosmos Health to Manufacture 500,000 Units of CBD Products For Australian Firm	09/07
Cosmos Health Expands Collaboration with Papaellinas in Cyprus	02/07
Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products	02/07
Sector Update: Health Care Stocks Retreat Late Afternoon	01/07
Cosmos Health Signs Distribution Deal for Sky Premium Life Nutraceuticals in Central Europe; Shares Rise	01/07
Cosmos Health Inc. Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for its Sky Premium Life Nutraceutical Products	01/07
Top Midday Gainers	28/06
Wall Street Set to Open Higher Friday as Key Inflation Data Indicates Cooling Inflation	28/06
Investors Await Key Inflation Data as US Futures Trend Higher Pre-Bell	28/06
Top Premarket Gainers	28/06
Cosmos Health Inc. Signs Exclusive Distribution Agreement with Pharmalink for its Sky Premium Life Nutraceuticals in the UAE	27/06
Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent	19/06
Cosmos Health to Acquire Full Rights to Patent Targeting Central Nervous System Cancers	18/06
Cosmos Health Participated in Vitafoods Europe 2024, Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand	20/05
Cosmos Health : Change in Certifying Accountants - Form 8-K	26/04
Cosmos Health : RELATED PARTY TRANSACTION POLICIES AND PROCEDURES - Form 8-K	22/03
Cosmos Health Inc. Commences Development of Cloudscreen 2.0 the New Iteration of Its Next Generation AI Drug Repurposing Platform	21/03
Cosmos Health Inc. Receives Regulatory Approval to Sell Sky Premium Life Products in UAE Nutritional Supplements Market	18/03
Cosmos Health Successfully Completes Acquisition of Pharmatrade's Assets, Expects to Increase FY 2024 Annual Revenue by over $5 Million	01/03
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company	21/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Cosmos Health Inc.

Actions

COSM

US2214133058

Autres langues

Filtres